ranibizumab

Italy

Drugs containing this active substance

  • BYOOVIZ

    It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO).

    Form: solution for injection

    Active substance Dosage
    ranibizumab -

    ATC: S01LA04

    Manufacturer: SAMSUNG BIOEPIS NL B.V.

  • It is used in adults to treat several eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO). In premature infants, it is used to treat retinopathy of prematurity (ROP).

    Form: solution for injection

    Active substance Dosage
    ranibizumab -

    ATC: S01LA04

    Manufacturer: NOVARTIS EUROPHARM LIMITED

  • It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy, diabetic macular edema, or retinal vein occlusion.

    Form: solution for injection

    Active substance Dosage
    ranibizumab -

    ATC: S01LA04

    Manufacturer: MIDAS PHARMA GMBH

  • It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO).

    Form: solution for injection

    Active substance Dosage
    ranibizumab -

    ATC: S01LA04

    Manufacturer: MIDAS PHARMA GMBH

  • It is used in adults to treat various eye diseases that cause vision loss, such as age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), and retinal vein occlusion (RVO).

    Form: solution for injection

    Active substance Dosage
    ranibizumab -

    ATC: S01LA04

    Manufacturer: STADA ARZNEIMITTEL AG